Detection of melanoma nodal metastases; Differences in detection between elderly and younger patients do not affect survival

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 3008-3014

  Kruijff, S ^a   Bastiaannet, E ^a   Suurmeijer, A J H ^a   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MELANOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 78649688076     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1085-1     Document Type: Article

References (37)

1. htpp:// www.ikcnet.nl.
2. CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit, et al. 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol. 19 3635 3648 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
3. AB Francken E Bastiaannet HJ Hoekstra 2005 Follow-up in patients with localised primary cutaneous melanoma Lancet Oncol. 6 608 621 10.1016/S1470-2045(05)70283-7 16054572 (Pubitemid 41051939)
4. E de Vries FI Bray JW Coebergh DM Parkin 2003 Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia Int J Cancer. 107 119 126 10.1002/ijc.11360 12925966 (Pubitemid 37100095)
5. LA Goldsmith FB Askin AE Chang C Cohen MD Dutcher RS Gilgor, et al. 1992 Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma JAMA. 268 1314 1319 10.1001/jama.268.10.1314
6. C Garbe TK Eigentler 2007 Diagnosis and treatment of cutaneous melanoma: state of the art 2006 Melanoma Res. 17 117 127 10.1097/CMR.0b013e328042bb36 17496787 (Pubitemid 46673905)
7. AB Francken HM Shaw NA Accortt SJ Soong HJ Hoekstra JF Thompson 2007 Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines Ann Surg Oncol. 14 1924 1933 10.1245/s10434-007-9347-2 17357855 (Pubitemid 46870937)
8. AB Francken JF Thompson E Bastiaannet HJ Hoekstra 2008 Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up Ned Tijdschr Geneeskd. 152 557 562 1:STN:280:DC%2BD1c3kt1yqtQ%3D%3D 18402322
9. U Hofmann M Szedlak W Rittgen DG Jung D Schadendorf 2002 Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival Br J Cancer. 87 151 157 1:STN:280:DC%2BD38zmsVOruw%3D%3D 10.1038/sj.bjc.6600428 12107834
10. MM Mooney M Kulas B McKinley AM Michalek WG Kraybill 1998 Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma Ann Surg Oncol. 5 54 63 1:STN:280:DyaK1c7osFeqtQ%3D%3D 10.1007/BF02303765 9524709 (Pubitemid 28328059)
11. CR Shumate MM Urist WA Maddox 1995 Melanoma recurrence surveillance. Patient or physician based? Ann Surg 221 566 569 1:STN:280:DyaK2M3ms12isg%3D%3D 10.1097/00000658-199505000-00014 7748038
12. C Garbe A Paul H Kohler-Spath U Ellwanger W Stroebel M Schwarz, et al. 2003 Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol. 21 520 529 10.1200/JCO.2003.01.091 12560444 (Pubitemid 46606483)
13. M Weiss CL Loprinzi ET Creagan RJ Dalton P Novotny JR O'Fallon 1995 Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA. 274 1703 1705 1:STN:280:DyaK28%2FovV2gug%3D%3D 10.1001/jama.274.21.1703 7474276
14. MW Regan CD Reid RW Griffiths JC Briggs 1985 Malignant melanoma, evaluation of clinical follow up by questionnaire survey Br J Plast Surg. 38 11 14 1:STN:280:DyaL2M%2FpvVeksQ%3D%3D 10.1016/0007-1226(85)90080-3 3967106 (Pubitemid 15105387)
15. WJ Poo-Hwu S Ariyan L Lamb R Papac D Zelterman GL Hu, et al. 1999 Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma Cancer. 86 2252 2258 1:STN:280: DC%2BD3c%2FlvFGkug%3D%3D 10.1002/(SICI)1097-0142(19991201)86:11<2252::AID- CNCR12>3.0.CO;2-Q 10590365 (Pubitemid 30010365)
16. DK Moore Q Zhou KS Panageas MS Brady DP Jaques DG Coit 2008 Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy Ann Surg Oncol. 15 2206 2214 10.1245/s10434-008-9985-z
17. PA Kersey NA Iscoe JA Gapski D Osoba L From G DeBoer, et al. 1985 The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma Br J Surg. 72 614 617 1:STN:280:DyaL2M3otFWlsQ%3D%3D 10.1002/bjs.1800720810 4027532 (Pubitemid 15047613)
18. TJ Dicker GM Kavanagh RM Herd T Ahmad KM McLaren U Chetty, et al. 1999 A rational approach to melanoma follow-up in patients with primary cutaneous melanoma Scottish Melanoma Group. Br J Dermatol. 140 249 254 1:STN:280:DyaK1M3kvF2ntw%3D%3D
19. CA Baughan VL Hall BJ Leppard PJ Perkins 1993 Follow-up in stage I cutaneous malignant melanoma: an audit Clin Oncol (R Coll Radiol) 5 174 180 1:STN:280:DyaK3szkvFOrtg%3D%3D
20. N Basseres JJ Grob MA Richard X Thirion H Zarour C Noe, et al. 1995 Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 191 199 203 1:STN:280:DyaK287hvFylsA%3D%3D 10.1159/000246546 8534937
21. DM Moloney DJ Gordon JC Briggs HS Rigby 1996 Recurrence of thin melanoma: how effective is follow-up? Br J Plast Surg. 49 409 413 1:STN:280: DyaK2s%2Fjs1WnsA%3D%3D 10.1016/S0007-1226(96)90012-0 8881790 (Pubitemid 26302626)
22. H Kittler R Weitzdorfer H Pehamberger K Wolff M Binder 2001 Compliance with follow-up and prognosis among patients with thin melanomas Eur J Cancer. 37 1504 1509 1:STN:280:DC%2BD3MvmtF2quw%3D%3D 10.1016/S0959-8049(01)00153-8 11506957 (Pubitemid 32744680)
23. P Sylaidis D Gordon H Rigby J Kenealy 1997 Follow-up requirements for thick cutaneous melanoma Br J Plast Surg. 50 349 353 1:STN:280: DyaK2szovVKgtw%3D%3D 10.1016/S0007-1226(97)90544-0 9245869 (Pubitemid 27312145)
24. CM Balch JE Gershenwald SJ Soong JF Thompson MB Atkins DR Byrd, et al. 2009 Final version of 2009 AJCC melanoma staging and classification J Clin Oncol. 27 6199 6206 10.1200/JCO.2009.23.4799 19917835
25. E Bastiaannet WJ Oyen S Meijer OS Hoekstra T Wobbes PL Jager, et al. 2006 Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients Br J Surg. 93 243 249 1:STN:280: DC%2BD28%2FmsVWiug%3D%3D 10.1002/bjs.5174 16323165 (Pubitemid 43259613)
26. S Ariyan WJ Poo J Bolognia A Buzaid T Ariyan 1995 Multiple primary melanomas: data and significance Plast Reconstr Surg. 96 1384 1389 1:STN:280:DyaK28%2Fms1yitg%3D%3D 10.1097/00006534-199511000-00023 7480238
27. A Brobeil D Rapaport K Wells CW Cruse F Glass N Fenske, et al. 1997 Multiple primary melanomas: implications for screening and follow-up programs for melanoma Ann Surg Oncol. 4 19 23 1:STN:280:DyaK2s7jvVCrtQ%3D%3D 10.1007/BF02316806 8985513
28. TM Johnson T Hamilton L Lowe 1998 Multiple primary melanomas J Am Acad Dermatol. 39 422 427 1:STN:280:DyaK1cvgvFWmtA%3D%3D 10.1016/S0190-9622(98)70318- 4 9738776 (Pubitemid 28417378)
29. PF Austin CW Cruse G Lyman K Schroer F Glass DS Reintgen 1994 Age as a prognostic factor in the malignant melanoma population Ann Surg Oncol. 1 487 494 1:STN:280:DyaK2M7ltlCiug%3D%3D 10.1007/BF02303614 7850555
30. BJ Averbook LJ Russo EG Mansour 1998 A long-term analysis of 620 patients with malignant melanoma at a major referral center Surgery. 124 746 755 1:STN:280:DyaK1cvlsVarsA%3D%3D 10.1067/msy.1998.91269 9780997 (Pubitemid 28463273)
31. CM Balch SJ Soong AA Bartolucci MM Urist CP Karakousis TJ Smith, et al. 1996 Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger Ann Surg. 224 255 263 1:STN:280:DyaK28vgvVajuw%3D%3D 10.1097/00000658-199609000-00002 8813254 (Pubitemid 26307468)
32. HJ Cohen E Cox K Manton M Woodbury 1987 Malignant melanoma in the elderly J Clin Oncol. 5 100 106 1:STN:280:DyaL2s7htFKksg%3D%3D 3806154
33. B Loggie SG Ronan J Bean TK Das Gupta 1991 Invasive cutaneous melanoma in elderly patients Arch Dermatol. 127 1188 1193 1:STN:280:DyaK3MzitFahtg%3D%3D 10.1001/archderm.127.8.1188 1863077
34. S Sahin B Rao AW Kopf E Lee DS Rigel R Nossa, et al. 1997 Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model Cancer. 80 1426 1431 1:STN:280:DyaK2svnvVWksw%3D%3D 10.1002/(SICI)1097-0142(19971015)80:8<1426::AID-CNCR9>3.0.CO;2-C 9338466 (Pubitemid 27441016)
35. WC Conway MB Faries MB Nicholl AM Terando EC Glass M Sim, et al. 2009 Age-related lymphatic dysfunction in melanoma patients Ann Surg Oncol. 16 1548 1552 10.1245/s10434-009-0420-x 19277787
36. AB Francken HJ Hoekstra 2009 Follow-up of melanoma patients: the need for evidence-based protocols Ann Surg Oncol. 16 804 805 10.1245/s10434-009-0318-7 19189190
37. http://dissertations.ub.rug.nl/FILES/faculties/medicine/2007/a.b. francken/melfo.pdf.